A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs

The objective of this work was the comparative evaluation of the healing process after employing 4/0 poliglecaprone 25 and 4/0 polyglytone 6211 in a continuous intradermal suture pattern. Ten Beagle dogs were used, in which skin incisions were created surgically and subsequently were sutured by mean...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pagona Gouletsou, Nikitas Prassinos, Lysimachos Papazoglou, Polychronis Kostoulas, Apostolos Galatos
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	canine polyglytone 6211 poliglecaprone 25 intradermal wound healing Veterinary medicine SF600-1100 Zoology QL1-991
Acceso en línea:	https://doaj.org/article/eaa809ca75434b0e890bd82c0c71b76a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:eaa809ca75434b0e890bd82c0c71b76a
record_format	dspace
spelling	oai:doaj.org-article:eaa809ca75434b0e890bd82c0c71b76a2021-11-25T16:15:06ZA Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs10.3390/ani111130942076-2615https://doaj.org/article/eaa809ca75434b0e890bd82c0c71b76a2021-10-01T00:00:00Zhttps://www.mdpi.com/2076-2615/11/11/3094https://doaj.org/toc/2076-2615The objective of this work was the comparative evaluation of the healing process after employing 4/0 poliglecaprone 25 and 4/0 polyglytone 6211 in a continuous intradermal suture pattern. Ten Beagle dogs were used, in which skin incisions were created surgically and subsequently were sutured by means of continuous intradermal pattern using polyglytone 6211 or poliglecaprone 25 suture. Cosmetic, clinical, and histologic scores were evaluated. The cosmetic appearance of the wounds was blindly evaluated on days 7, 14, 28, 180, 360, 730, and 1095. On the same days, tissue biopsy was performed for histological evaluation. Clinical evaluation was performed initially daily, then weekly, monthly, and finally yearly, till day 1095. The clinical appearance of the intradermal pattern with both sutures was initially very good, deteriorated in the second post-operative month and thereafter improved. The cosmetic, clinical, and histological differences between the two suture materials were minimal and statistically insignificant. Polyglytone 6211 is sufficient for use in intradermal suturing in dogs. However, its earlier absorption compared to poliglecaprone 25 did not have any beneficial effect on cutaneous wound healing and scar appearance in the experimental animals.Pagona GouletsouNikitas PrassinosLysimachos PapazoglouPolychronis KostoulasApostolos GalatosMDPI AGarticlecaninepolyglytone 6211poliglecaprone 25intradermalwound healingVeterinary medicineSF600-1100ZoologyQL1-991ENAnimals, Vol 11, Iss 3094, p 3094 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	canine polyglytone 6211 poliglecaprone 25 intradermal wound healing Veterinary medicine SF600-1100 Zoology QL1-991
spellingShingle	canine polyglytone 6211 poliglecaprone 25 intradermal wound healing Veterinary medicine SF600-1100 Zoology QL1-991 Pagona Gouletsou Nikitas Prassinos Lysimachos Papazoglou Polychronis Kostoulas Apostolos Galatos A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs
description	The objective of this work was the comparative evaluation of the healing process after employing 4/0 poliglecaprone 25 and 4/0 polyglytone 6211 in a continuous intradermal suture pattern. Ten Beagle dogs were used, in which skin incisions were created surgically and subsequently were sutured by means of continuous intradermal pattern using polyglytone 6211 or poliglecaprone 25 suture. Cosmetic, clinical, and histologic scores were evaluated. The cosmetic appearance of the wounds was blindly evaluated on days 7, 14, 28, 180, 360, 730, and 1095. On the same days, tissue biopsy was performed for histological evaluation. Clinical evaluation was performed initially daily, then weekly, monthly, and finally yearly, till day 1095. The clinical appearance of the intradermal pattern with both sutures was initially very good, deteriorated in the second post-operative month and thereafter improved. The cosmetic, clinical, and histological differences between the two suture materials were minimal and statistically insignificant. Polyglytone 6211 is sufficient for use in intradermal suturing in dogs. However, its earlier absorption compared to poliglecaprone 25 did not have any beneficial effect on cutaneous wound healing and scar appearance in the experimental animals.
format	article
author	Pagona Gouletsou Nikitas Prassinos Lysimachos Papazoglou Polychronis Kostoulas Apostolos Galatos
author_facet	Pagona Gouletsou Nikitas Prassinos Lysimachos Papazoglou Polychronis Kostoulas Apostolos Galatos
author_sort	Pagona Gouletsou
title	A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs
title_short	A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs
title_full	A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs
title_fullStr	A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs
title_full_unstemmed	A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs
title_sort	controlled trial of polyglytone 6211 versus poliglecaprone 25 for use in intradermal suturing in dogs
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/eaa809ca75434b0e890bd82c0c71b76a
work_keys_str_mv	AT pagonagouletsou acontrolledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs AT nikitasprassinos acontrolledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs AT lysimachospapazoglou acontrolledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs AT polychroniskostoulas acontrolledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs AT apostolosgalatos acontrolledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs AT pagonagouletsou controlledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs AT nikitasprassinos controlledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs AT lysimachospapazoglou controlledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs AT polychroniskostoulas controlledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs AT apostolosgalatos controlledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs
_version_	1718413290474831872

A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs

Ejemplares similares